Lurasidone
Back to searchMolecule Structure
Scientific Name
Lurasidone
Description of the Drug
Lurasidone is an atypical antipsychotic used to treat schizophrenia and depressive episodes associated with bipolar I disorder.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08815
http://www.drugbank.ca/drugs/DB08815
Brand Name(s)
Latuda
Company Owner(s)
Amneal Pharmaceuticals Co Gmbh, Teva Pharmaceuticals Usa Inc, Alembic Pharmaceuticals Ltd, Piramal Healthcare Uk Ltd, Watson Laboratories Inc An Indirect Wholly Owned Sub Of Teva Pharmaceuticals Usa Inc, Invagen Pharmaceuticals Inc, Sun Pharmaceutical Industries Ltd, Accord Healthcare Inc, Dr Reddys Laboratories Ltd, Emcure Pharmaceuticals Ltd
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Dopamine D2 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL217 |
Serotonin 2a (5-HT2a) receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL224 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL677525 | ||
PharmGKB | PA166129557 | ||
DrugBank | DB08815 | ||
PubChem: Thomson Pharma | 16247346 | ||
PubChem | 213046 | ||
LINCS | LSM-45843 | ||
Nikkaji | J2.437.646J | ||
BindingDB | 85222 | ||
DrugCentral | 4168 | ||
ChemicalBook | CB22498821 | CB32500192 | |
Guide to Pharmacology | 7461 | ||
rxnorm | LURASIDONE HYDROCHLORIDE | LURASIDONE | LATUDA |
ChEBI | 70735 | ||
ZINC | ZINC000003927822 |